News
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...
20h
Zacks Investment Research on MSNPfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold?Pfizer's PFE stock has risen 5% since it reported first-quarter results on April 29. While the company beat estimates for ...
Pfizer recorded lower first-quarter revenue on a 75% drop in sales of its Covid-19 treatment, which more than offset growth ...
Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...
Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...
Pfizer (PFE) stock slips after the company's lower than expected Q1 2025 revenue and the firm seeks acquisitions to boost its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results